Concepedia

Author

Nina Mitchell

BioMarin (United States)

Also Known As

N Mitchell, N. Mitchell, N.R. Mitchell, Nina Mitchell, Zanon, Ezio

18

Publications

1K

Citations

9

H-Index

14

Concepts

All Affiliations

BioMarin (United States)University Hospital Southampton NHS Foundation TrustLa Jolla Alcohol ResearchGuy's and St Thomas' NHS Foundation TrustImperial College London
NM

About

Nina Mitchell is an author at BioMarin (United States) specializing in rheumatoid arthritis, immunology, and rheumatic diseases.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

94

2

Immunology

3

3

94

3

Rheumatology

3

3

94

4

Autoimmune Disease

3

3

94

5

Orthopaedics

2

2

53

Nina Mitchell

×

9

Publications

1K

Citations

9

H-Index

YearCitations

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A

John Pasi, Savita Rangarajan, Nina Mitchell,

New England Journal of Medicine

2020

441

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

Gerd R Burmester, William F. C. Rigby, Ronald van Vollenhoven,

Annals of the Rheumatic Diseases

2015

193

Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A

Sylvia Fong, Bridget Yates, Choong‐Ryoul Sihn,

Nature Medicine

2022

106

Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A

John Pasi, Michael Laffan, Savita Rangarajan,

Haemophilia

2021

95

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A

Brian Long, P. Véron, Klaudia Kuranda,

Molecular Therapy

2020

71

Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study

Christopher D. Buckley, Jesus Abraham Simón Campos, Brandon Becker,

The Lancet Rheumatology

2020

41

OP0041 Tocilizumab (TCZ) in Combination and Monotherapy Versus Methotrexate (MTX) in MTX-Naive Patients (PTS) with Early Rheumatoid Arthritis (RA): Clinical and Radiographic Outcomes from a Randomised, Placebo-Controlled Trial

Gerd R Burmester, William F. C. Rigby, Ronald van Vollenhoven,

Annals of the Rheumatic Diseases

2013

28

MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study

Mark C. Genovese, Mario Berkowitz, Philip G. Conaghan,

The Lancet Rheumatology

2020

27

The antigen induced arthritis model: the relevance of the method of induction to its use as a model of human disease.

Prue Howson, N Shepard, Nina Mitchell

PubMed

1986

26

Page 1